Cytokine Assay Testing Services

The National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, is seeking cytokine assay testing services for the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) cohort study. The requirement involves quantitatively analyzing cytokine levels from 665 human blood serum samples, specifically measuring concentrations of IL-1B, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12(p70), GM-CSF, IFN-y, and TNF-A. Interested contractors must submit detailed capability statements demonstrating technical proficiency, with a preference for methods utilizing small sample volumes. The sources sought notice is classified under NAICS code 541380 for Testing Laboratories and Services, and responses must be electronically submitted to kevin.alvarez@nih.gov by December 19, 2024, at 9:00 AM ET. Evaluation will focus on the contractor's ability to meet the technical requirements and demonstrate specialized laboratory testing capabilities.

The pre-solicitation notice is open to small businesses, including HUBZone, Service-Disabled Veteran-Owned Small Businesses (SDVOSB), 8(a), Veteran-Owned Small Businesses (VOSB), Women-Owned Small Businesses (WOSB), and small disadvantaged businesses. No specific set-aside has been designated, and no incumbent contractor information is provided in the notice. The period of performance is scheduled for January 20, 2025, through January 19, 2026, spanning a full 12-month contract period. While no specific budget range or award value is mentioned, the scope involves testing 665 human blood serum samples for comprehensive cytokine level analysis. The solicitation number is 75N95025Q00081, and it is important to note that this is a sources sought notice, meaning no contract will be awarded based on the initial responses.